Q3 2025 SANUWAVE Health Inc Earnings Call Transcript
Key Points
- SANUWAVE Health Inc (SNWV) achieved an all-time record revenue quarter in Q3 2025, with a 22% year-over-year increase.
- The company sold 155 ultimate systems in Q3, marking another all-time record and contributing to a total of 1,416 units in the field.
- Gross margins were healthy at 77.9%, reflecting strategic pricing initiatives and cost management.
- SANUWAVE Health Inc (SNWV) received a $5 million payment for the exercise of IP licensing related to its intravascular shockwave patent portfolio.
- The company successfully refinanced its debt, reducing it from $27.5 million to $24 million and lowering the interest rate significantly.
- Operating income for Q3 2025 was down by $0.5 million compared to the same period last year.
- Operating expenses increased by $2.4 million year-over-year, driven by higher non-cash stock-based compensation and increased headcount expenses.
- The wound care market was unsettled in Q3 due to changes in reimbursement policies, causing some practitioners to adopt a wait-and-see approach.
- Gross margins slightly decreased from the previous quarter due to lower ASP for ultimate systems when working with larger resellers.
- The company faced challenges in the reseller model, with concerns about inventory management and potential channel stuffing.
Please stand by. Your program is about to begin.
Good day everyone and welcome to the Sanu wave earnings call. At this time, all participants are in a listen-only mode. Later you will have the opportunity to ask questions during the question-and-answer session. You may register to ask a question at any time by pressing the and 1 on your telephone keypad. You may withdraw yourself from the queue by pressing and 2.
Please note this call may be recorded and I will be standing by if you should need any assistance. It is now my pleasure to turn the conference over to Morgan Frank, Chairman and CEO of Stanuave. Please go ahead.
Thank you. Good morning. Welcome to Sandy Wave's 3rd quarter 2025 earnings call. Form 10-Q was filed with the SEC last night. Our earnings release was issued this morning, and our updated presentation was made available on the website in the investor section. Please refer to that during your presentation. We really TRY to make it useful. Thanks. So joining me on the call today is Peter
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
